North America Infectious Respiratory Disease Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Infectious Respiratory Disease Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the infectious respiratory disease diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
North America infectious respiratory disease diagnostics market highlights
- The North America infectious respiratory disease diagnostics market generated a revenue of USD 5,492.1 million in 2024.
- The market is expected to grow at a CAGR of 2.6% from 2025 to 2033.
- In terms of segment, reagents was the largest revenue generating product in 2024.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 5,492.1 million |
| Market revenue in 2033 | USD 6,870.9 million |
| Growth rate | 2.6% (CAGR from 2025 to 2033) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, North America region accounted for 44.7% of the global infectious respiratory disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,635.6 million by 2033.
North America is the largest region in the market, owing to increasing adoption of diagnostic products due to its high accuracy, sensitivity, and specificity. Increasing requirement of tests for diagnosis of diseases, such as tuberculosis, RSV, influenza A & B, and COVID-19 is expected to drive market growth.
Increasing number of strategic partnerships among manufacturers of testing kits and In Vitro Diagnostics (IVD) companies for the development of novel techniques makes North America a lucrative market for infectious respiratory disease diagnostics.
Favorable government initiatives and reimbursement policies are likely to drive market growth. The New Technology Add-on Payment (NTAP) program has been introduced by the CMS to reduce financial losses for hospitals.
No credit card required*
Publish Date: Jan 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
North America Infectious Respiratory Disease Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Respiratory Disease Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.71% in 2024.
Horizon Databook has segmented the North America infectious respiratory disease diagnostics market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
North America is the largest region in the market, owing to increasing adoption of diagnostic products due to its high accuracy, sensitivity, and specificity. Increasing requirement of tests for diagnosis of diseases, such as tuberculosis, RSV, influenza A & B, and COVID-19 is expected to drive market growth.
Increasing number of strategic partnerships among manufacturers of testing kits and In Vitro Diagnostics (IVD) companies for the development of novel techniques makes North America a lucrative market for infectious respiratory disease diagnostics.
Favorable government initiatives and reimbursement policies are likely to drive market growth. The New Technology Add-on Payment (NTAP) program has been introduced by the CMS to reduce financial losses for hospitals.
- North America Infectious Respiratory Disease Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents
- Services
- North America Infectious Respiratory Disease Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Molecular Diagnostics
- Immunoassays
- Microbiology
- Rapid/Point-of-Care Diagnostics
- Other Technologies
- North America Infectious Respiratory Disease Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- COVID-19
- Influenza
- Tuberculosis
- Respiratory Syncytial Virus (RSV)
- Non-tuberculosis Mycobacterium Testing
- Bacterial Pneumonia Testing
- Other Respiratory Diseases
- North America Infectious Respiratory Disease Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
Reasons to subscribe to Infectious Respiratory Disease Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Respiratory Disease Diagnostics Market Outlook databook
- Our clientele includes a mix of Infectious Respiratory Disease Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Infectious Respiratory Disease Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Infectious Respiratory Disease Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Infectious Respiratory Disease Diagnostics Market, 2021-2033 (US$M)
North America Product - Infectious Respiratory Disease Diagnostics Market Statistics, 2024 - 2033 (US$M)
